120-character summary: Low late-pregnancy 25(OH)D levels are not associated with offspring parent-reported respiratory symptoms and infections.
Recently, there has been an increasing interest in immunomodulatory effects of vitamin D. Several studies have suggested detrimental effects of insufficient 25-hydroxyvitamin D (25(OH)D) levels on the innate and acquired immune system which may contribute to the development of infections, and atopic and allergic conditions [1] [2] [3] [4] . Children as well as pregnant and lactating women have been identified as groups with a high risk of 25(OH)D insufficiency [5] . Low maternal serum 25(OH)D levels in pregnancy may contribute to increased risk of offspring infections and atopic outcomes. Previous studies demonstrate inconsistency regarding relationships between maternal vitamin D intake, serum 25(OH)D levels and umbilical cord 25(OH)D levels with these outcomes in offspring [6] [7] [8] [9] [10] . We aimed to explore relationships between maternal serum 25(OH)D levels during late pregnancy and parent-reported respiratory tract symptoms and doctor-diagnosed lower respiratory tract infections (LRTI) in early childhood in a large cohort study .
The study sample consisted of 2025 mother-child pairs from the Southampton Women's Survey with maternal serum 25(OH)D measurement at 34 weeks' gestation (Diasorin RIA, Diasorin, Stillwater, US) [11] . Follow-up was at children's age 6 months (n=2026), 12 months (n=1946) and 2 years (n=1876).
Parents were asked whether the child had suffered from any of the following since the last visit: one or more episodes of chest wheezing/whistling, waking at night coughing three or more nights in a row (prolonged cough), one or more episodes of croup or a croupy cough, bouts of vomiting or diarrhoea lasting 2 days or longer, or a doctor-diagnosed chest infection, bronchitis, bronchiolitis, pneumonia and/or ear infection. Chest infection, bronchitis, bronchiolitis and pneumonia were combined into one variable labelled "lower respiratory tract infection" (LRTI). Binary variables were created for each outcome. Relative risks were calculated by Poisson regression with robust variance with serum 25(OH)D>75 nmol/l as reference category [12] . All analyses were adjusted for child's sex, birthweight and gestational age, and for maternal age at childbirth, educational level, pre-pregnancy BMI, parity, ethnicity, smoking in pregnancy, and breast feeding duration. All analyses are adjusted for child's sex, birthweight and gestational age, and for maternal age at childbirth, educational level, pre-pregnancy BMI, parity, ethnicity, smoking in pregnancy, and duration of breast feeding.
